Doris Po Yi Ho

Title: **Doris Po Yi Ho: Pioneering Cancer Treatment Innovations**

Introduction

Doris Po Yi Ho is an accomplished inventor located in Daly City, California, recognized for her significant contributions to cancer treatment through her innovative research and patented technologies. With a total of three patents to her name, Dr. Ho's work is at the forefront of advancing medical solutions for cancer, particularly through dual-targeting methodologies.

Latest Patents

One of Dr. Ho’s latest patents focuses on the **treatment of cancer with dual targeting of CD47 and EGFR**. This patent outlines methods for targeting cells for depletion, including cancer cells, by utilizing a regimen that involves contacting the targeted cells with a combination of agents. The regimen includes (i) an agent that blockades CD47 activity and (ii) an antibody that specifically binds to EGFR. Notably, in some embodiments, the cancer cells targeted may possess mutated forms of one or more of KRAS, NRAS, or BRAF. The methodology outlined enhances the level of depletion of the targeted cells compared to regimens utilizing a single agent, demonstrating potential synergistic effects that underline the innovative nature of her work.

Career Highlights

Dr. Doris Po Yi Ho currently works at **Leland Stanford Junior University**, where she engages in cutting-edge research that significantly impacts cancer treatment strategies. Her commitment to scientific advancement is reflected in her comprehensive research studies and innovative methodologies, which push the boundaries of current medical practices.

Collaborations

In her pursuit of groundbreaking innovations, Dr. Ho collaborates with esteemed colleagues such as Irving L. Weissman and Stephen Willingham. These partnerships enhance her research capabilities and foster a collaborative environment that is crucial for advancing innovative healthcare solutions.

Conclusion

Doris Po Yi Ho stands as a noteworthy inventor in the field of cancer treatment, driven by her passion for innovation and dedication to improving patient outcomes. Her patent contributions, particularly in the dual-targeting of cancer cells, highlight her role as a leader in medical research. With her ongoing efforts, Dr. Ho continues to inspire future innovations that may ultimately transform cancer therapy.